Pulse Biosciences, Inc.
PLSE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,016,709 | $587,985 | $94,000 | $414,147 |
| - Cash | $118,038 | $44,365 | $61,139 | $28,614 |
| + Debt | $8,898 | $9,144 | $75,957 | $11,250 |
| Enterprise Value | $907,569 | $552,764 | $108,818 | $396,783 |
| Revenue | $0 | $0 | $700 | $1,418 |
| % Growth | – | -100% | -50.6% | – |
| Gross Profit | $0 | -$1,207 | -$11,244 | -$550 |
| % Margin | – | – | -1,606.3% | -38.8% |
| EBITDA | -$55,079 | -$42,367 | -$56,702 | -$61,868 |
| % Margin | – | – | -8,100.3% | -4,363% |
| Net Income | -$53,585 | -$42,210 | -$58,505 | -$63,660 |
| % Margin | – | – | -8,357.9% | -4,489.4% |
| EPS Diluted | -0.92 | -0.88 | -1.72 | -2.28 |
| % Growth | -4.5% | 48.8% | 24.6% | – |
| Operating Cash Flow | -$36,343 | -$33,041 | -$47,013 | -$54,097 |
| Capital Expenditures | -$125 | -$121 | -$401 | -$437 |
| Free Cash Flow | -$36,468 | -$33,162 | -$47,414 | -$54,534 |